» Articles » PMID: 37176611

A Novel Constitutional T(3;8)(p26;q21) and and Variants in a Child with Myelodysplastic Neoplasm: Clinical Implications

Abstract

Background: Childhood myelodysplastic neoplasm (cMDS) often raises concerns about an underlying germline predisposition, and its verification is necessary to guide therapeutic choice and allow family counseling. Here, we report a novel constitutional t(3;8)(p26;q21) in a child with MDS, inherited from the father, the and variants from the maternal origin, and the acquisition of molecular alterations during MDS evolution.

Case Presentation: A 4-year-old girl showed repeated infections and severe neutropenia. Bone marrow presented hypocellularity with dysplastic features. The patient had a t(3;8)(p26;q21)c identified by G-banding and FISH analysis. The family nucleus investigation identified the paternal origin of the chromosomal translocation. The NGS study identified and variants of maternal origin. CGH-array analysis detected alterations in and genes. Immunohistochemistry showed abnormal p53 expression during the MDS evolution.

Conclusion: This study shows for the first time, cytogenetic and genomic abnormalities inherited from the father and mother, respectively, and their clinical implications. It also shows the importance of investigating patients with constitutional cytogenetic alterations and/or germline variants to provide information to their family nucleus for genetic counseling and understanding of the pathogenesis of childhood MDS.

Citing Articles

Germline and Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome.

Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsaether M Cancer Genomics Proteomics. 2024; 21(3):272-284.

PMID: 38670586 PMC: 11059592. DOI: 10.21873/cgp.20446.

References
1.
Fejzo M, Chen H, Anderson L, McDermott M, Karlan B, Konecny G . Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition. Gynecol Oncol. 2020; 160(2):539-546. DOI: 10.1016/j.ygyno.2020.11.008. View

2.
Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

3.
Schoemaker M, Jones M, Higgins C, Wright A, Swerdlow A . Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study. Am J Epidemiol. 2018; 188(3):500-508. PMC: 6395160. DOI: 10.1093/aje/kwy266. View

4.
Avagyan S, Shimamura A . Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies. Front Oncol. 2022; 12:813149. PMC: 8959480. DOI: 10.3389/fonc.2022.813149. View

5.
Li X, Wu L, Corsa C, Kunkel S, Dou Y . Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol Cell. 2009; 36(2):290-301. PMC: 2768600. DOI: 10.1016/j.molcel.2009.07.031. View